Display Settings:

Format

Send to:

Choose Destination

    Protein Expr Purif. 1997 Apr;9(3):301-8.

    Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discovery.

    Horlick RA, Sperle K, Breth LA, Reid CC, Shen ES, Robbins AK, Cooke GM, Largent BL.

    Applied Biotechnology Department, DuPont Merck Pharmaceutical Co., Wilmington, Delaware 19880-0400, USA.

    Human HEK293 cells that stably express the Epstein Barr nuclear antigen 1 (EBNA1) support the episomal replication of plasmids containing the Epstein Barr virus origin of replication (EBV oriP). A 293EBNA (293E) cell line expressing the human corticotropin-releasing hormone receptor subtype I (CRHR1) from an episomal plasmid was generated (293CR1s), analyzed, adapted to spinner culture, and scaled-up for production in less than 6 weeks. Forty-seven stable CHO cell lines transfected with CRHR1 were also isolated. Expression of the receptor in the best of these lines (as judged by CRH-induced cAMP production), CHO-R22, was compared to that in 293CR1s cells. Results indicate that the CRHR1 episomal expression vector in 293E cells (1) rapidly generates stable cell lines suitable for scale-up; (2) is stably maintained during 3 months in culture; (3) expresses high levels of CRHR1 mRNA; and (4) expresses significantly more CRHR1 than the CHO-R22 line. Coexpression of additional G protein alpha subunit (G alpha s) with CRHR1 in 293E cells converts a higher percentage of receptor to the agonist high-affinity G-protein-coupled state. Our data support the idea that using the EBV oriP-driven episomal system for gene expression results in greater production of protein in a relatively short period of time.

    PMID: 9126600 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read